0001580149 1 2026-07-17 2026-07-17 0001580149 2 2026-07-17 2026-07-17 0001580149 3 2026-07-17 2026-07-17 0001580149 2026-07-17 2026-07-17 iso4217:USD pure S-1 EX-FILING FEES 0001580149 N/A N/A S-1 BioVie Inc. false Equity Class A Common Stock true 50000000.00 0.0001381 6905.00 false Other Pre-funded Warrants to purchase Class A Common Stock true 0.0001381 0.00 false Other Class A Common Stock underlying Pre-funded Warrants true 0.0001381 0.00 50000000.00 6905.00 0.00 6905.00 (1) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).<br/>(2) Pursuant to Rule 416 under the Securities Act, the securities registered hereby include an indeterminate number of additional securities as may become offered, issuable or sold by reason of stock splits, stock dividends, recapitalizations or similar transactions from time to time. (1) See Offering Note 1.<br/>(2) Pursuant to Rule 457(g) under the Securities Act, no separate registration fee is required for the pre-funded warrants issued in the offering. (1) See Offering Note 1.<br/>(2) The proposed maximum aggregate offering price of the Class A Common Stock, par value $0.0001 per share (the “Common Stock”) will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if any, is $50,000,000.